IP Verse

Chiesi Farmaceutici competitive analysis

Latest publications and patents of Chiesi Farmaceutici New

Explore the latest publications and patents granted to Chiesi Farmaceutici, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Chiesi Farmaceutici

EP4031117
Jul 24, 2024Agent For Use In Treatment Or Prevention Of Ophthalmic DisordersGranted And Under Opposition
EP2104490
Jun 26, 2024Micronised Particles Of Low-Dosage Strength Active Agents For Powder Formulations For InhalationPatent Maintained As Amended
EP3500241
Oct 4, 2023Combination Therapy For CopdGranted And Under Opposition
EP2890437
Dec 18, 2019Aerosol Inhalation DeviceRevoked
EP3384931
Jul 24, 2019Formoterol Superfine FormulationGranted And Under Opposition
EP3034073
Jun 12, 2019Use Of A Composition Comprising Formoterol And Beclometasone Dipropionate For The Prevention And/Or Treatment Of An Exacerbation Of AsthmaOpposition Rejected
EP3019153
Sep 5, 2018Dry Powder Formulation Comprising An Anticholinergic, A Corticosteroid And A Beta-Adrenergic For Administration By InhalationGranted And Under Opposition
EP2806855
Jul 11, 2018Dry Powder Formulation Comprising A Corticosteroid And A Beta-Adrenergic For Administration By InhalationOpposition Rejected
EP2552424
May 9, 2018Process For Preparing Carrier Particles For Dry Powders For InhalationOpposition Rejected
EP3004097
Jan 17, 2018Kinase InhibitorsNo Opposition Filed Within Time Limit

Latest oppositions filed by Chiesi Farmaceutici

Explore patent oppositions filed by Chiesi Farmaceutici against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3471805
Drug Delivery Device With ElectronicsNORTON WATERFORDFeb 14, 2020
EP2897588
An Inhalable MedicamentTEVA PHARMACEUTICALSFeb 6, 2020
EP3344607
Solid State Forms Of SelexipagTEVA PHARMACEUTICALSFeb 6, 2020
EP1646417
Inhaler ApparatusCIPLA EUAug 8, 2019
EP2824174
Mesenchymal Stem Cells And Uses ThereforMESOBLASTAug 7, 2019
EP3071272
Inhaler DeviceCIPLAAug 5, 2019

Latest patents of Chiesi Farmaceutici opposed by its competitors

Explore Chiesi Farmaceutici's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP4031117
Jul 24, 2024Agent For Use In Treatment Or Prevention Of Ophthalmic Disorders1
EP2104490
Jun 26, 2024Micronised Particles Of Low-Dosage Strength Active Agents For Powder Formulations For Inhalation1
EP3500241
Oct 4, 2023Combination Therapy For Copd3
EP2890437
Dec 18, 2019Aerosol Inhalation Device2
EP3384931
Jul 24, 2019Formoterol Superfine Formulation1
EP3034073
Jun 12, 2019Use Of A Composition Comprising Formoterol And Beclometasone Dipropionate For The Prevention And/Or Treatment Of An Exacerbation Of Asthma3
EP3019153
Sep 5, 2018Dry Powder Formulation Comprising An Anticholinergic, A Corticosteroid And A Beta-Adrenergic For Administration By Inhalation1
EP2806855
Jul 11, 2018Dry Powder Formulation Comprising A Corticosteroid And A Beta-Adrenergic For Administration By Inhalation1
EP2552424
May 9, 2018Process For Preparing Carrier Particles For Dry Powders For Inhalation2
EP2560611
Jan 3, 2018"Process For Providing Particles With Reduced Electrostatic Charges"1

Latest PTAB cases involving Chiesi Farmaceutici

Discover the latest PTAB cases involving Chiesi Farmaceutici, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Chiesi Farmaceutici with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
CHIESI FARMACEUTICI618 - - Balanced
LIPOMED2 - - - Highly Aggressive
LUPIN HEALTHCARE UK2 - - - Highly Aggressive
TEVA PHARMACEUTICALS20515 - 12Highly Aggressive